CQP Stock Cheniere Energy Partners, L.P.
US · NYSELast in our picks 2026-10-26 — not in the current list; analysis below is from that screen
Contracted LNG cash flows and distribution stability provide defensive energy exposure with moderate upside.
Future value: $60.00 (-9.30%) · 6-12 months · analyst consensus
Signal breakdown
- ▸Consensus remains Moderate Buy after recent analyst target increases.
- ▸Above 50-day MA (+0.5%)
- ▸Above 200-day MA — long-term uptrend
- ▸Near 52-week high (76.3% of range) — strength
- ▾Trading above its price target — limited upside
Is CQP a buy right now?
Trend: CQP is trading above the 50-day average (+0.76%), RSI 68 — neutral momentum, with a 3-month return of +3.42%.
Valuation & quality: Cheniere Energy Partners, L.P. trades on a trailing P/E of 12.0, forward P/E 14.1, PEG 5.05, price-to-book 8.69; fundamentals show net margin 27.3%, return on equity 1516.9%, revenue growth 5.2% year on year.
Analyst consensus: 13 analysts have a mean 12-month price target of $60.00 (-9.5% vs the last close; range $51.00 – $67.00), consensus rating “underperform”.
Income: trailing dividend yield 4.93%.
Our screen: BUY (score 2) — Contracted LNG cash flows and distribution stability provide defensive energy exposure with moderate upside.
Computed from end-of-day data; not personal advice.
12-month price chart
Monthly returns
| Mar 26 | Apr 26 | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|---|---|
| +5.40% | +3.70% | -11.90% | +3.20% | +8.10% | +6.70% | -13.40% | +8.90% |
Fundamentals
Analyst price target
Technical signals
About Cheniere Energy Partners, L.P.
Cheniere Energy Partners, L.P., through its subsidiaries, provides liquefied natural gas (LNG) to integrated energy companies, utilities, and energy trading companies in the United States and internationally.
Sector: Energy · Industry: Oil & Gas Midstream · United States · Website
Related Energy picks
Browse: all US stocks · Energy picks · today's movers
Market data from end-of-day feeds; AI-generated research for educational purposes only — not investment advice.